Search Results - "SOOS, M. A"

Refine Results
  1. 1

    Elevated Plasma Adiponectin in Humans with Genetically Defective Insulin Receptors by Semple, R. K., Soos, M. A., Luan, J., Mitchell, C. S., Wilson, J. C., Gurnell, M., Cochran, E. K., Gorden, P., Chatterjee, V. K. K., Wareham, N. J., O’Rahilly, S.

    “…Context: Adiponectin has been suggested to play a role in the etiopathogenesis of at least some forms of insulin resistance, in part based on a strong…”
    Get full text
    Journal Article
  2. 2

    Severe insulin resistance due to anti‐insulin antibodies: response to plasma exchange and immunosuppressive therapy by Greenfield, J. R., Tuthill, A., Soos, M. A., Semple, R. K., Halsall, D. J., Chaudhry, A., O’Rahilly, S.

    Published in Diabetic medicine (01-01-2009)
    “…Anti‐insulin antibodies have been described in two contexts: in insulin‐naive individuals (so‐called ‘insulin autoimmune syndrome’) and in patients with…”
    Get full text
    Journal Article
  3. 3

    Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension by O'Rahilly, S, Barroso, I, Gurnell, M, Crowley, V. E. F, Agostini, M, Schwabe, J. W, Soos, M. A, Maslen, G. LI, Williams, T. D. M, Lewis, H, Schafer, A. J, Chatterjee, V. K. K

    Published in Nature (London) (23-12-1999)
    “…Thiazolidinediones are a new class of antidiabetic agent that improve insulin sensitivity and reduce plasma glucose and blood pressure in subjects with type 2…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Founder effect in the Horn of Africa for an insulin receptor mutation that may impair receptor recycling by Raffan, E., Soos, M. A., Rocha, N., Tuthill, A., Thomsen, A. R., Hyden, C. S., Gregory, J. W., Hindmarsh, P., Dattani, M., Cochran, E., Al Kaabi, J., Gorden, P., Barroso, I., Morling, N., O’Rahilly, S., Semple, R. K.

    Published in Diabetologia (01-05-2011)
    “…Aims/hypothesis Genetic insulin receptoropathies are a rare cause of severe insulin resistance. We identified the Ile119Met missense mutation in the insulin…”
    Get full text
    Journal Article
  6. 6

    Functional characterization of a novel insulin receptor mutation contributing to Rabson-Mendenhall syndrome by Tuthill, A., Semple, R. K., Day, R., Soos, M. A., Sweeney, E., Seymour, P. J., Didi, M., O'Rahilly, S.

    Published in Clinical endocrinology (Oxford) (01-01-2007)
    “…Summary Objective/Patients  Rabson–Mendenhall syndrome (RMS) is a rare, recessively inherited disorder of extreme insulin resistance due to mutations in the…”
    Get full text
    Journal Article
  7. 7

    Defect in Insulin-Like Growth Factor-1 Survival Mechanism in Atherosclerotic Plaque-Derived Vascular Smooth Muscle Cells Is Mediated by Reduced Surface Binding and Signaling by Patel, V A, Zhang, Q.-J, Siddle, K, Soos, M A, Goddard, M, Weissberg, P L, Bennett, M R

    Published in Circulation research (11-05-2001)
    “…ABSTRACT—Apoptosis of vascular smooth muscle cells (VSMCs) is increased in atherosclerosis compared with normal vessels, where it may contribute to plaque…”
    Get full text
    Journal Article
  8. 8

    Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors by Siddle, K, Ursø, B, Niesler, C A, Cope, D L, Molina, L, Surinya, K H, Soos, M A

    Published in Biochemical Society transactions (01-08-2001)
    “…The physiological roles of insulin and insulin-like growth factors (IGFs) are distinct, with insulin acting to regulate cellular uptake and metabolism of…”
    Get more information
    Journal Article
  9. 9

    Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity by SOOS, M. A, FIELD, C. E, SIDDLE, K

    Published in Biochemical journal (01-03-1993)
    “…Hybrid insulin/insulin-like growth factor-I (IGF-I) receptors have previously been described in human placenta, but it has not been possible to study their…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies by Malek, R., Chong, A. Y., Lupsa, B. C., Lungu, A. O., Cochran, E. K., Soos, M. A., Semple, R. K., Balow, J. E., Gorden, P.

    “…Background: Type B insulin resistance belongs to a class of diseases caused by an autoantibody to a cell surface receptor. Blockade of insulin action results…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Deletion of V335 from the L2 Domain of the Insulin Receptor Results in a Conformationally Abnormal Receptor That Is Unable to Bind Insulin and Causes Donohue’s Syndrome in a Human Subject by George, S, Johansen, A, Soos, M. A, Mortensen, H, Gammeltoft, S, Saudek, V, Siddle, K, Hansen, L, O’Rahilly, S

    Published in Endocrinology (Philadelphia) (01-02-2003)
    “…An infant with Donohue’s syndrome (leprechaunism) was found to be homozygous for an in-frame trinucleotide deletion within the insulin receptor gene resulting…”
    Get full text
    Journal Article
  15. 15

    Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants by SCHUMACHER, R, SOOS, M. A, SCHLESSINGER, J, BRANDENBURG, D, SIDDLE, K, ULLRICH, A

    Published in The Journal of biological chemistry (15-01-1993)
    “…Chimeric receptors were generated in which structurally defined subdomains of the insulin receptor (IR) and insulin growth factor-I receptor (IGF-1R)…”
    Get full text
    Journal Article
  16. 16

    Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors by Soos, M A, Siddle, K

    Published in Biochemical journal (15-10-1989)
    “…The receptors for insulin and insulin-like growth factor-I (IGF-I) are closely related in primary sequence and overall structure. We have examined the…”
    Get full text
    Journal Article
  17. 17

    Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells by Soos, M A, Whittaker, J, Lammers, R, Ullrich, A, Siddle, K

    Published in Biochemical journal (01-09-1990)
    “…We have demonstrated the formation of hybrid insulin/insulin-like growth factor-I(IGF-I) receptors in transfected rodent fibroblasts, which overexpress human…”
    Get full text
    Journal Article
  18. 18

    Hypoglycemia and resistance to ketoacidosis in a subject without functional insulin receptors by OGILVY-STUART, A. L, SOOS, M. A, HANDS, S. J, ANTHONY, M. Y, DUNGER, D. B, O'RAHILLY, S

    “…Humans with congenital absence of the islets of Langerhans and mice rendered null for the insulin receptor rapidly develop severe hyperglycemia and…”
    Get full text
    Journal Article
  19. 19

    A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity by SOOS, M. A, FIELD, C. E, LAMMERS, R, ULLRICH, A, BEI ZHANG, ROTH, R. A, ANDERSEN, A. S, KJELDSEN, T, SIDDLE, K

    Published in The Journal of biological chemistry (25-06-1992)
    “…We obtained 20 mouse monoclonal antibodies specific for human type I insulin-like growth factor (IGF) receptors, using transfected cells expressing high levels…”
    Get full text
    Journal Article
  20. 20

    Transdominant Inhibition of Tyrosine Kinase Activity in Mutant Insulin/ Insulin-Like Growth Factor I Hybrid Receptors by Treadway, Judith L., Morrison, Brian D., Soos, Maria A., Siddle, Kenneth, Olefsky, Jerrold, Ullrich, Axel, McClain, Donald A., Pessin, Jeffrey E.

    “…Classical insulin and insulin-like growth factor I (IGF-I) receptors exist as well defined α2β2heterotetrameric complexes that are assembled from two identical…”
    Get full text
    Journal Article